164 related articles for article (PubMed ID: 8195318)
1. Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.
Benkerrou M; Wara DW; Elder M; Dror Y; Merino A; Colombe BW; Garovoy M; Cowan MJ
J Clin Immunol; 1994 Mar; 14(2):98-106. PubMed ID: 8195318
[TBL] [Abstract][Full Text] [Related]
2. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation.
Shiobara S; Lum LG; Witherspoon RP; Storb R
Transplantation; 1986 May; 41(5):587-92. PubMed ID: 2939606
[TBL] [Abstract][Full Text] [Related]
4. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
Gerritsen EJ; Van Tol MJ; Van 't Veer MB; Wels JM; Khouw IM; Touw CR; Jol-Van Der Zijde CM; Hermans J; Rümke HC; Radl J
Blood; 1994 Dec; 84(12):4374-82. PubMed ID: 7994052
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
Chu E; Umetsu D; Rosen F; Geha RS
J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-tetanus toxoid antibody production induced by Epstein-Barr virus from B cells of human marrow transplant recipients.
Jin NR; Lum LG
Cell Immunol; 1986 Aug; 101(1):266-73. PubMed ID: 2427210
[TBL] [Abstract][Full Text] [Related]
7. B cell development and regulation after T cell-depleted marrow transplantation.
Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
[TBL] [Abstract][Full Text] [Related]
8. IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells.
Lum LG; Burns E; Janson MM; Martin PJ; Giddings BR; Seigneuret MC; Noges JE; Galoforo SC
J Clin Immunol; 1990 Sep; 10(5):255-64. PubMed ID: 2176226
[TBL] [Abstract][Full Text] [Related]
9. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.
Lum LG; Culbertson NJ
J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow.
Welte K; Keever CA; Levick J; Bonilla MA; Merluzzi VJ; Mertelsmann R; Evans R; O'Reilly RJ
Blood; 1987 Nov; 70(5):1595-603. PubMed ID: 3311208
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation.
Dror Y; Gallagher R; Wara DW; Colombe BW; Merino A; Benkerrou M; Cowan MJ
Blood; 1993 Apr; 81(8):2021-30. PubMed ID: 8471764
[TBL] [Abstract][Full Text] [Related]
12. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient.
Geha RS; Rosen FS
J Immunol; 1989 Jul; 143(1):84-8. PubMed ID: 2567317
[TBL] [Abstract][Full Text] [Related]
13. [Antigen-specific antibody response in allogeneic bone marrow transplantation patients: in vivo and in vitro antibody production after the primary immunization with tetanus toxoid. Kanazawa University Bone Marrow Transplantation Team].
Otsuka M; Shiobara S; Harada M; Ueda M; Mori T; Matsue K; Matsuda T
Rinsho Ketsueki; 1990 Mar; 31(3):301-7. PubMed ID: 2366332
[TBL] [Abstract][Full Text] [Related]
14. Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts.
Lum LG; Noges JE; Beatty P; Martin PJ; Deeg J; Doney KC; Loughran T; Sullivan KM; Witherspoon RP; Thomas ED
Bone Marrow Transplant; 1988 Sep; 3(5):399-406. PubMed ID: 3056548
[TBL] [Abstract][Full Text] [Related]
15. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
Kodo H; Gale RP; Saxon A
J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
[TBL] [Abstract][Full Text] [Related]
16. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
Roberts JL; Volkman DJ; Buckley RH
J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo.
Böcher WO; Marcus H; Shakarchy R; Dekel B; Shouval D; Galun E; Reisner Y
Immunology; 1999 Apr; 96(4):634-41. PubMed ID: 10233752
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
Knutsen AP; Wall DA
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
[TBL] [Abstract][Full Text] [Related]
20. Elevated inflammatory cytokine levels in bone marrow graft rejection.
Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
Transplantation; 1995 Nov; 60(9):943-8. PubMed ID: 7491698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
